Latest News
The SEAS Trial Debated
Medscape | 28 minutes ago
While numerous experts say the results provide little new information and won't alter clinical practice, some see the data as positive for Vytorin, especially in light of the wealth of evidence showing the benefit of lowering LDL-cholesterol levels.... (more)
ABC News: Drugs Add 13 Years to Lives of HIV Patients
ABC News | 2 hours 1 minute ago
WASHINGTON (Reuters) - Cocktails of HIV drugs help patients live an average of 13 years longer -- if they are lucky enough to get them, researchers reported on Thursday.BRASILIA, BRAZIL: Bottles of Kaletra, of the Abbott Laboratories, are displayed at a pharmacy in... BRASILIA, BRAZIL: Bottles of Kaletra, of the Abbott Laboratories, are displayed at a pharmacy in Brasilia, 30 June 2005. Brazilian Health Minister Humberto Costa said Monday he was aiming to halve the cost of Kaletra, a key HIV...... (more)
Pfizer fined for lying about rival's products
Sydney Morning Herald, The | 2 hours 7 minutes ago
THE pharmaceutical giant Pfizer has been fined a record $200,000 after its representatives told doctors that a rival company's anti-cholesterol product was associated with kidney problems. - Sydney Morning Herald Online... (more)
Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction*
Journal of Biological Chemistry | 2 hours 29 minutes ago
The small leucine-rich proteoglycan (SLRP) family has significantly expanded in the past decade to now encompass five discrete classes, grouped by common structural and functional properties.... (more)
Osiris stem cell line sale OK'd
Sun (Baltimore), The | 7 hours 48 minutes ago
Osiris Therapeutics' shareholders approved yesterday the sale of the stem cell drugmaker's only product line, a bone-regeneration treatment called Osteocel, in a transaction worth up to $137 million, which will be used for the company's next generation of drugs.... (more)
Harvard stem cell research gets boost
Boston Globe, The | 11 hours 8 minutes ago
British drug giant GlaxoSmithKline has agreed to sponsor at least $25 million in work at the Harvard Stem Cell Institute in Cambridge, one of the largest investments in stem cell research ever by a major pharmaceuticals company.... (more)
Genentech Reviews Roche Takeover Bid
Wall Street Journal, The | 11 hours 13 minutes ago
Genentech Inc. said late Thursday it won't act on Roche Group AG's $89-a-share takeover bid until the deal is evaluated by a special committee of three members of its board.... (more)
Genentech Weighs Takeover - NYTimes.com
New York Times, The | 13 hours 13 minutes ago
Genentech said Thursday that the company had formed a special committee, consisting of its three independent board members, to consider a takeover bid from Roche Holding. The committee’s chairman, Charles A. Sanders, called Roche’s offer “unsolicited and unexpected.” On Monday, Roche announced a bid of $89 a share for the 44 percent of Genentech stock it did not own.... (more)
Affymetrix cuts full-year revenue outlook
Forbes | 14 hours 37 minutes ago
SANTA CLARA, Calif. - Affymetrix Inc., which makes the GeneChip system for genetic data analysis, cut its full-year revenue outlook because of weakness in its pharmaceutical business, sending shares in a nosedive during after-hours trading.... (more)
Affymetrix swings to 2Q loss on revenue decline
Forbes | 14 hours 37 minutes ago
SANTA CLARA, Calif. - Affymetrix Inc., which makes the GeneChip system for genetic data analysis, said Thursday it swung to a second-quarter loss on lower revenue and a restructuring charge.... (more)
Genentech convenes committee to consider Roche bid
Forbes | 14 hours 37 minutes ago
SOUTH SAN FRANCISCO, Calif. - Genentech Inc. says the company has officially formed a special committee consisting of its three independent board members to consider Roche Holding's takeover bid.... (more)
Genentech committee reviewing Roche offer
Reuters | 15 hours 12 minutes ago
By Deena BeasleyLOS ANGELES (Reuters) - Genentech Inc (DNA.N: Quote, Profile, Research, Stock Buzz) said on Thursday a special committee of its three independent directors is assessing the proposal from Roche AG (ROG.VX: Quote, Profile, Research, Stock Buzz) to acquire the shares of the biotechnology company it does not already own.... (more)
191 Stories | 
RSS Feed
Sign up for BIO SmartBrief
Latest Blog Postsview more
Protein Transporter for Lutein and Zeaxanthin, Identified
BioTech Weblog, The
Research Services for Life Sciences, Launched by Symyx
BioTech Weblog, The
Genentech Forms Special Committee of Independent Directors to Review Roche Proposal
Eye on FDA
Chemist goes nano with CoQ10
Science Blog
Companies in the news
- AmeriPath
- Amgen Inc
- Amylin Pharmaceuticals Inc.
- Applied Biosystems Group
- Barr Pharmaceuticals Inc
- Biogen IDEC Inc.
- Genentech
- Icon PLC
- Merck & Co Inc
- Mirus Bio Corporation
- Pfizer Inc.
- Quest Diagnostics Inc
- Ranbaxy Laboratories Limited
- Roche Holding
- South Bend